Glen Gejerman, MD, MBA

Hackensack University Medical Center

Hackensack, NJ

Disclosures:

Presentations

Sep 28

114 - Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate Cancer

02:30pm - 02:40pm PT